Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study

2021 ◽  
Vol 173 ◽  
pp. 108681
Author(s):  
Luca D'Onofrio ◽  
Carmen Mignogna ◽  
Angela Carlone ◽  
Ermanno Bellizzi ◽  
Michela Di Guida ◽  
...  
2010 ◽  
Vol 24 (S1) ◽  
Author(s):  
Cyril WC Kendall ◽  
Amin Esfahani ◽  
Tina L Parker ◽  
Monica S Banach ◽  
Sandra Mitchell ◽  
...  

Diabetes Care ◽  
2004 ◽  
Vol 27 (12) ◽  
pp. 2898-2904 ◽  
Author(s):  
A. Juutilainen ◽  
S. Kortelainen ◽  
S. Lehto ◽  
T. Ronnemaa ◽  
K. Pyorala ◽  
...  

2017 ◽  
Vol 31 (6) ◽  
pp. 952-957 ◽  
Author(s):  
Saula Vigili de Kreutzenberg ◽  
Anna Solini ◽  
Edoardo Vitolo ◽  
Alessandra Boi ◽  
Simonetta Bacci ◽  
...  

2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Ritsuko Yamamoto-Honda ◽  
Hideki Ehara ◽  
Hiroji Kitazato ◽  
Yoshihiko Takahashi ◽  
Shoji Kawazu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document